Investor Presentation

August 3, 2026 Listing Department, Listing Department, National Stock Exchange of India Limited BSE Limited Exchange Plaza, Bandra-Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Dalal Street, Mumbai – 400 051 Mumbai – 400 001 NSE Symbol: ARTEMISMED Scrip Code: 542919 Sub: Earning Presentation - Q1 FY 27 Dear Sir/Ma’am, With reference to the captioned subject, please find attached herewith the earning presentation for the quarter ended June 30, 2026. The presentation is also available on the website of the Company at www.artemishospitals.com/investors. This is for your information and records. Thanking you, Yours faithfully, For Artemis Medicare Services Limited Poonam Makkar Company Secretary & Compliance Officer Encl: As above R: 191 G: 176 B: 65 R: 255 G: 196 B: 63 R: 170 G: 127 B: 0 R: 245 G: 206 B: 70 R: 158 G: 139 B: 56 R: 235 G: 177 B: 0 Investor Presentation R: 189 G: 142 B: 0 Q1 FY 27 R: 155 G: 152 B: 109 R: 237 G: 125 B: 49 R: 191 G: 176 B: 65 R: 255 G: 196 B: 63 R: 170 G: 127 B: 0 R: 245 G: 206 B: 70 R: 158 G: 139 B: 56 R: 235 G: 177 B: 0 R: 189 G: 142 B: 0 R: 155 G: 152 B: 109 R: 237 G: 125 B: 49 Performance Highlights (Gurgaon) Q1 FY 27 R: 191 G: 176 B: 65 R: 255 G B: : 1 69 36 Re Ov pe en rau tie onfr som E OB pI eT rD aA tio f nro sm Bed Occupancy (%) A AR RP PO OB B IP Volume R: 170 G: 127 Y Q1 FY 27 Q1 FY 27 Q1 FY 27 Q1 FY 27 Q1 FY 27 B: 0 o INR27,849Lacs INR5,626Lacs 65.7% INR85,690 9,181 R: 245 15.4% 32.1% 443 bps 7.4% 11.4% G: 206 B: 70 Q1 FY 26 Q1 FY 26 Q1 FY 26 Q1 FY 26 Q1 FY 26 R: 158 INR 24,125 Lacs INR 4,259 Lacs 61.2% INR 79,752 8,242 G: 139 B: 56 R: 235 G: 177 B: 0 Revenue from EBITDA from R: 189 Operations Operations Bed Occupancy (%) ARPOB IP Volume G: 142 B: 0 Q Q1 FY 27 Q1 FY 27 Q1 FY 27 Q1 FY 27 Q1 FY 27 R: 155 o INR27,849Lacs INR5,626Lacs 65.7% INR85,690 9,181 G: 152 Q B: 109 4.1% 8.8% 106 bps 1.3% 5.4% R: 237 G: 125 Q4 FY 26 Q4 FY 26 Q4 FY 26 Q4 FY 26 Q4 FY 26 B: 49 INR 26,746 Lacs INR 5,170 Lacs 64.6% INR 84,571 8,712 Performance Highlights (Consolidated) Q1 FY 27 R: 191 G: 176 B: 65 R: 255 G: 196 Revenue from EBITDA from ARPOB B: 63 Operations Operations EBITDA (%) PAT EPS (Diluted) R: 170 G: 127 Y Q1 FY 27 Q1 FY 27 Q1 FY 27 Q1 FY 27 Q1 FY 27 B: 0 o INR28,732Lacs INR5,644Lacs 19.6% INR 3,144 Lacs INR1.98 R: 245 12.7% 36.4% 341 bps 48.3% 46.7% G: 206 B: 70 Q1 FY 26 Q1 FY 26 Q1 FY 26 Q1 FY 26 Q1 FY 26 R: 158 INR 25,496 Lacs INR 4,139 Lacs 16.2% INR 2,120 Lacs INR 1.35 G: 139 B: 56 R: 235 G: 177 B: 0 Revenue from EBITDA from R: 189 Operations Operations EBITDA (%) PAT EPS (Diluted) G: 142 B: 0 Q Q1 FY 27 Q1 FY 27 Q1 FY 27 Q1 FY 27 Q1 FY 27 R: 155 o INR28,732Lacs INR5,644Lacs 19.6% INR3,144 INR 1.98 G: 152 Q B: 109 2.9% 9.4% 117 bps 3.8% 4.2% R: 237 G: 125 Q4 FY 26 Q4 FY 26 Q4 FY 26 Q4 FY 26 Q4 FY 26 B: 49 INR 27,923 Lacs INR 5,159 Lacs 18.5% INR 3,028 INR 1.90 Long-Term Value Creation Drivers 1 Integrated Healthcare Platform with Multiple Growth Engines • ~800 operational beds across flagship Gurugram hospital and allied healthcare platforms R: 191 • Strong presence across quaternary care, cardiac care and international healthcare delivery G: 176 B: 65 • Diversified platform with multiple growth drivers across hospitals, cardiac care centres and international R: 255 operations G: 196 B: 63 • Scalable healthcare platform supported by a strong brand, cliInPi cVaollu emxecellence and disciplined expansion R: 170 strategy G: 127 B: 0 2 Consistent Earnings Growth with Industry-Leading Operating Metrics R: 245 G: 206 B: 70 • Strong financial track record with 3-year Revenue, EBITDA and PAT CAGRs of 14%, 29% and 40%, respectively R: 158 G: 139 • Operational EBITDA margin expanded from 16% to 20%+ over the last 5-quarters, driven by operating leverage, B: 56 disciplined cost management, and execution excellence R: 235 G: 177 • Strong earnings momentum, with EPS growing at a CAGR of 32% over the last 3-years B: 0 • Industry-leading ARPOB at the Gurgaon facility, underpinned by a differentiated tertiary and quaternary care mix, R: 189 G: 142 delivering a 3-year CAGR of 9%+ B: 0 R: 155 G: 152 3 Multi-Year Capacity Expansion with Strong Growth Visibility B: 109 R: 237 • 300+ bed Raipur super speciality hospital operational since July 2026, strengthening presence in Central India G: 125 B: 49 • 650+ bed South Delhi hospital to strengthen presence in the premium Delhi NCR healthcare market • Bed capacity to expand to ~2,000 over the next 3–5 years, supporting long-term growth visibility • Phased capacity expansion to drive operating leverage and earnings growth Long-Term Value Creation Drivers 4 High-Acuity Clinical Platform Supporting Premium Realisations • 14 Centres of Excellence across 40+ specialties delivering advanced quaternary care R: 191 • ~60% of revenue generated from high-acuity specialties, supporting premium realisations G: 176 B: 65 • Market-leading expertise in oncology, transplants, robotic surgery and advanced critical care R: 255 • Strategic partnership with KIMS to establish Heart & Lung Transplant programme, strengthening G: 196 B: 63 high-acuity clinical capabilities IP Volume R: 170 G: 127 B: 0 5 Global Medical Value Travel Platform with Premium Economics R: 245 G: 206 B: 70 • ~27–30% of revenue derived from international patients, among the highest in the listed hospital sector R: 158 G: 139 • Well-diversified international patient base spanning over 150+ countries B: 56 • Established partnerships across Africa, CIS, the Middle East and SAARC nations drive sustainable patient R: 235 G: 177 inflows B: 0 • High-value international case mix supports premium ARPOB and superior earnings quality R: 189 G: 142 B: 0 R: 155 G: 152 6 Operational Excellence with Proven Execution B: 109 R: 237 • Strong clinician retention enabling continuity of care and premium case mix G: 125 B: 49 • AI-enabled clinical and operational workflows driving efficiency and improved patient outcomes • Operational discipline supporting efficient asset utilisation and margin improvement • Experienced leadership team driving disciplined growth and long-term value creation Welcome to the World of Artemis R: 191 G: 176 B: 65 R: 255 Artemis Hospitals, promoted by the Apollo Tyres Group, operates a G: 196 B: 63 700-bed super speciality hospital in Gurugram (Delhi-NCR) and a R: 170 G: 127 B: 0 newly commissioned 300+ bed super speciality hospital in Raipur R: 245 G: 206 (July 2026), with a clear roadmap to expand its capacity to ~2,000 B: 70 R: 158 beds by 2030 G: 139 B: 56 R: 235 G: 177 B: 0 R: 189 Topoftheline State-of-the-Art G: 142 AdvancedTechnology TertiaryCare Hospital B: 0 R: 155 14 Centres of 1st JCI Accredited Hospital G: 152 B: 109 Excellence in Gurgaon R: 237 G: 125 40+ Medical 500+ Business Tie-ups with B: 49 Specialities Corporates 150+ 500+ Doctors Countries Patients R: 191 G: 176 B: 65 R: 255 G: 196 B: 63 R: 170 G: 127 B: 0 R: 245 G: 206 B: 70 R: 158 G: 139 B: 56 R: 235 G: 177 B: 0 R: 189 G: 142 B: 0 R: 155 G: 152 B: 109 R: 237 G: 125 B: 49 R: 191 G: 176 B: 65 R: 255 G: 196 B: 63 R: 170 G: 127 B: 0 R: 245 G: 206 B: 70 R: 158 G: 139 B: 56 R: 235 G: 177 B: 0 R: 189 G: 142 B: 0 R: 155 G: 152 B: 109 R: 237 G: 125 B: 49 R: 191 G: 176 B: 65 R: 255 G: 196 B: 63 R: 170 G: 127 B: 0 R: 245 G: 206 B: 70 R: 158 G: 139 B: 56 R: 235 G: 177 B: 0 R: 189 G: 142 B: 0 R: 155 G: 152 B: 109 R: 237 G: 125 B: 49 R: 191 G: 176 B: 65 R: 255 G: 196 B: 63 R: 170 G: 127 B: 0 R: 245 G: 206 B: 70 R: 158 G: 139 B: 56 R: 235 G: 177 B: 0 R: 189 G: 142 B: 0 R: 155 G: 152 B: 109 R: 237 G: 125 B: 49 R: 191 G: 176 B: 65 R: 255 G: 196 B: 63 R: 170 G: 127 B: 0 R: 245 G: 206 B: 70 R: 158 G: 139 B: 56 R: 235 G: 177 B: 0 R: 189 G: 142 B: 0 R: 155 G: 152 B: 109 R: 237 G: 125 B: 49 Highlights-Gurgaon Operational Highlights Financial Highlights • Strong patient volume growth, with IP volumes increasing 11.4% YoY to 9,181, reflecting • Revenue from operations grew 15.4% YoY to INR 27,849 Lacs, led by R: 191 sustained demand across specialties. G: 176 higher [Showing first 8,000 characters — download PDF for full document]